Log In
BCIQ
Print this Print this
 

ONO-2952

  Manage Alerts
Collapse Summary General Information
Company Ono Pharmaceutical Co. Ltd.
DescriptionPeripheral benzodiazepine receptor (TSPO; PBR) antagonist
Molecular Target Peripheral benzodiazepine receptor (TSPO) (PBR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat irritable bowel syndrome (IBS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today